The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations
2023
Gray JE, Salomonsen R, Georgoulia N, Perez ID, Wang A, Cai L, Wetherill G, Xiao Y, Fielden C, Altorki NK